Highlights ease of deployment, value, and
extensibility of comprehensive Oracle platform
ORLANDO, Fla. , Feb. 3, 2025
/PRNewswire/ -- SCOPE 2025 – Oracle Life Sciences has
been named a 'Leader' in the Everest Group Life Sciences Clinical
Trial Management System (CTMS) Products PEAK Matrix® Assessment
2024. This designation underscores Oracle's ongoing commitment to
transforming clinical trial management through innovative and
cost-effective solutions designed to support healthcare systems and
life sciences organizations worldwide.
As the life sciences industry evolves, driven by increasing
trial complexities, regulatory demands, and the need for real-time
insights, Oracle continues to redefine the industry standard for
CTMS platforms. Oracle's Siebel CTMS platform enables integration
with Electronic Health Records (EHR) for seamless data flow between
investigators, Contract Research Organizations (CROs), and
sponsors, integration with Electronic Data Capture (EDC), and other
critical systems, and adherence to diverse regulatory
standards.
"Being designated as a 'Leader' by Everest Group in its
assessment of our CTMS validates Oracle's mission to deliver
cutting-edge technology that accelerates innovation and helps
improve outcomes in life sciences," said Seema Verma, executive vice president and
general manager, Oracle Health and Life Sciences. "We are
harnessing the full power of Oracle's expertise in data and AI to
deliver platforms like CTMS, purpose-built to address the unique
challenges of pharma and healthcare systems. Our solution is
compliant, secure, cost-effective, and globally adaptable,
empowering organizations to drive innovation and efficiency in
clinical research and care delivery."
The evaluation highlights Oracle's strengths in providing a
comprehensive solution to critical trial management and its
abilities to accommodate diverse regulatory requirements globally.
The report further highlights Oracle's competitive pricing and
seamless integration with critical clinical systems, including EDC,
Clinical Data Management Systems (CDMS), electronic trial master
file (eTMF), payment, analytics, and regulatory systems.
"The CTMS market is rapidly evolving in response to growing
trial complexity, the need for real-time collaboration, and diverse
data sources' integration," said Nisarg
Shah, practice director, Everest Group. "Providers are now
delivering comprehensive trial data management solutions that offer
enhanced features to elevate the quality of information
provided."
"Oracle's Siebel CTMS platform offers a comprehensive,
one-stop-shop solution for clinical trial management, providing
flexibility for customization to meet specific organizational
needs. Clients value the platform's seamless integration with
various critical clinical systems and analytics
solutions. Oracle's extensive global footprint, which helps deliver
consistent operations across regions, combined with its expansive
capabilities and competitive pricing have positioned Oracle as a
Leader in the Life Sciences Clinical Trial Management System (CTMS)
Products PEAK Matrix® Assessment 2024."
The Everest Group PEAK Matrix® is a proprietary framework for
assessing the relative market success and overall capability of
service providers based on performance, experiences, ability, and
knowledge. Each service provider is comparatively assessed on two
dimensions: market success and delivery capabilities. Market
success is measured by revenue, number of clients, and
year-over-year growth. Delivery capability is measured by scale of
operations, scope, technology and innovation, delivery footprint,
and buyer satisfaction. The resulting matrix categorizes service
providers as Leaders, Major
Contenders, and Aspirants.
To read the full Everest Group PEAK Matrix® report, visit:
https://www.everestgrp.com/peak-matrix/healthcare-and-life-sciences/life-sciences-clinical-trial-management-system-ctms-products.html
To read about Oracle and the Everest Group PEAK Matrix® for
Electronic Data Capture, visit:
https://www.oracle.com/news/announcement/oracle-life-sciences-positioned-as-a-leader-in-the-everest-group-peak-matrix-for-electronic-data-capture-2024-10-24/
About Oracle Life Sciences
Oracle Life Sciences is a
leader in cloud technology, pharmaceutical research, and
consulting, trusted globally by professionals in both large and
emerging companies engaged in clinical research and
pharmacovigilance, throughout the therapeutic development
lifecycle, including pre- and post-drug launch activities. With
more than 20 years of experience, Oracle Life Sciences is committed
to supporting clinical development and leveraging real-world
evidence to deliver innovation and accelerate advancements –
empowering the life sciences industry to improve patient outcomes.
Learn more at oracle.com/lifesciences
About Oracle
Oracle offers integrated suites of
applications plus secure, autonomous infrastructure in the Oracle
Cloud. For more information about Oracle (NYSE: ORCL), please visit
us at www.oracle.com.
Disclaimer
Licensed extracts taken from Everest Group's PEAK Matrix® Reports,
may be used by licensed third parties for use in their own
marketing and promotional activities and collateral. Selected
extracts from Everest Group's PEAK Matrix® reports do not
necessarily provide the full context of our research and analysis.
All research and analysis conducted by Everest Group's analysts and
included in Everest Group's PEAK Matrix® reports is independent and
no organization has paid a fee to be featured or to influence their
ranking. To access the complete research and to learn more
about our methodology, please visit Everest Group PEAK Matrix®
Reports.
About Everest Group
Everest Group is a leading global research firm helping business
leaders make confident decisions. Everest Group's PEAK
Matrix® assessments provide the analysis and insights enterprises
need to make critical selection decisions about global services
providers, locations, and products and solutions within various
market segments. Likewise, providers of these services, products,
and solutions, look to the PEAK Matrix® to gauge and calibrate
their offerings against others in the industry or market. Find
further details and in-depth content
at www.everestgrp.com.
Trademarks
Oracle, Java, MySQL and NetSuite are
registered trademarks of Oracle Corporation. NetSuite was the first
cloud company—ushering in the new era of cloud computing.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/oracle-recognized-as-a-leader-in-everest-group-peak-matrix-for-life-sciences-clinical-trial-management-system-ctms-assessment-2024-302365733.html
SOURCE Oracle
